Adjuvanted Malaria Vaccine Dose Reduction Strategy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current malaria vaccination methods, such as the RTS,S/AS01 regimen, often require full doses in multiple administrations, which can be reactogenic and may not induce long-lasting immunity effectively.
Innovation Solution
A method involving an initial full dose of an adjuvanted malaria vaccine followed by a booster dose with a lower amount of antigen and adjuvant, specifically using a TLR4 agonist like 3D-MPL and an immunologically active saponin such as QS21, where the second dose has a reduced amount of the common component compared to the first, enhancing immune response without using an oil-in-water emulsion formulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If full doses are administered in multiple vaccinations, then the immune response is strengthened, but reactogenicity increases
Solution Approach 1:
The patent applies parameter changes by varying the dose amount across different vaccination administrations. Specifically, it uses a higher dose in the first administration and a lower dose in subsequent administrations, thereby optimizing the balance between immune response strength and reactogenicity. This dose parameter modification allows the vaccine to maintain effectiveness while reducing adverse reactions in later doses.
2Reliability
If the same dose is administered in subsequent vaccinations, then the immune response is maintained, but long-lasting immunity is not effectively induced
Solution Approach 1:
The patent implements periodic action through a structured multi-dose vaccination schedule with specific timing intervals. The regimen administers doses at predetermined time points (e.g., month 0, month 1, month 6, month 12) rather than using continuous or identical dosing. This periodic administration pattern, combined with varying doses, effectively induces long-lasting immunity by stimulating the immune system at optimal intervals.
3Object-affected harmful factors
If a reduced dose is given in the second administration, then reactogenicity is minimized, but immune response strength may be compromised
Solution Approach 1:
The patent applies preliminary action by administering a higher dose in the first vaccination to establish a strong initial immune response and priming the immune system. This preliminary high-dose administration creates a foundation that allows subsequent lower doses to maintain and boost immunity without causing excessive reactogenicity. The initial strong stimulation prepares the immune system for effective response to later reduced doses.
Data Source
AI summary
Methods of inducing an immune response comprising at least two administrations of an adjuvanted immunogenic composition, wherein the second administration contains reduced amounts of antigen and adjuvant.